Clinical Trial Update: rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates rHSC-DIPGVax in combination with checkpoint blockade for newly diagnosed diffuse intrinsic pontine glioma and diffuse midline gliom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Diffuse Midline Glioma H3 K27m-mutant

Drugs mentioned

• Checkpoint blockade (PD-1/PD-L1 inhibitor)
• rHSC-DIPGVax

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant | Phase 1 | Status: RECRUITING